Effect of Vamana Karma in Pre-Diabetic Patients.

Effect of Vamana Karma on the Disease Specific Biomarkers of Diabetes in Pre-Diabetic Patients - A Single Arm Open Label Clinical Trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052545

Enrollment

Registered

2023-05-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E748- Other specified disorders of carbohydrate metabolism

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients of age group 18 to 60 years of either sex. 2)The HbA1C levels should lie within the range of 5.7 to 6.4 ( A/C to American Diabetes Association, ADA ,2022 guidelines)

Exclusion criteria

Exclusion criteria: 1)Patients with Type 1 or Type 2 diabetes mellitus. 2)Patients with Gestational diabetes mellitus or pregnant women . 3)Patients who are not fit for Vamana karma such as ati-sthula , ati- krisha, durbala and who will not be fit for vamana karma( at the time of enrollment) will not be included . 4)Patients suffering from any chronic diseases such as bronchial asthma , COPD, chronic kidney disease , ischaemic heart diseases , fatty liver stage 3 and chronic illness of other body organs , uncontrolled high blood pressure ( >160/100 mm of Hg) 5)Patients who are diagnosed with malignancy of any system.

Design outcomes

Primary

Measure	Time frame
The proportion of Pre-diabetic patients classed as treatment success using HbA1C levels post vamana karma.Timepoint: 70-80 days post completion of Sansarjana krama for 3,5,7 days as per type of shuddhi .	—

Secondary

Measure	Time frame
1)The proportion of Pre-diabetic patients showing reduction in the C-Peptide levels, FBS and PPBS levels post vamana karma. 2)Assessment of the effect of Vamana karma on subjective parameters through the validated questionnaire Timepoint: C-peptides -day 0 and day 70-80 post completion of sansarjana krama for 3,5,7 days as per type of shuddhi 2)FBS,PPBS, questionnaire - every 15th day post sansarjana krama	—

Measure

Time frame

1)The proportion of Pre-diabetic patients showing reduction in the C-Peptide levels, FBS and PPBS levels post vamana karma. 2)Assessment of the effect of Vamana karma on subjective parameters through the validated questionnaire Timepoint: C-peptides -day 0 and day 70-80 post completion of sansarjana krama for 3,5,7 days as per type of shuddhi 2)FBS,PPBS, questionnaire - every 15th day post sansarjana krama

—

Countries

India

Contacts

Public ContactDr Manisha

ayurvedic and Unani Tibbia College and Hospital ,New Delhi

manojshamkuwar@gmail.com9423039441

Outcome results